Psyomics
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
Total raised
€13M
€13,072,150
Funding rounds
3
Investors
4
distinct backers
Active since
2020-10
latest 2025-10
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood59
base rate 44% for Seed
- ▲ In typical raise window
- ▲ Up-round momentum
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 11y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-10 | Seed | €8.6M | — | View deal → |
| 2022-06-21 | Other | €2.8M | Meltwind,Newable Ventures,Parkwalk | View deal → |
| 2020-10-27 | Other | €1.7M | Parkwalk Advisors | View deal → |